578 related articles for article (PubMed ID: 33902708)
1. Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease.
Park JS; Kam TI; Lee S; Park H; Oh Y; Kwon SH; Song JJ; Kim D; Kim H; Jhaldiyal A; Na DH; Lee KC; Park EJ; Pomper MG; Pletnikova O; Troncoso JC; Ko HS; Dawson VL; Dawson TM; Lee S
Acta Neuropathol Commun; 2021 Apr; 9(1):78. PubMed ID: 33902708
[TBL] [Abstract][Full Text] [Related]
2. Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor/β-endorphin pathway.
Jia Y; Gong N; Li TF; Zhu B; Wang YX
Pharmacol Res; 2015 Dec; 102():276-85. PubMed ID: 26546042
[TBL] [Abstract][Full Text] [Related]
3. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
4. Activation of glucagon-like peptide-1 receptor in microglia attenuates neuroinflammation-induced glial scarring via rescuing Arf and Rho GAP adapter protein 3 expressions after nerve injury.
Qian Z; Chen H; Xia M; Chang J; Li X; Ye S; Wu S; Jiang S; Bao J; Wang B; Kong R; Zhang S; Zheng S; Cao X; Hong X
Int J Biol Sci; 2022; 18(4):1328-1346. PubMed ID: 35280691
[No Abstract] [Full Text] [Related]
5. Chlorzoxazone exhibits neuroprotection against Alzheimer's disease by attenuating neuroinflammation and neurodegeneration in vitro and in vivo.
Bai Y; Ma X
Int Immunopharmacol; 2020 Nov; 88():106790. PubMed ID: 32795892
[TBL] [Abstract][Full Text] [Related]
6. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
Lantz MJ; Roberts AM; Delgado DD; Nichols RA
J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory factors and amyloid β-induced microglial polarization promote inflammatory crosstalk with astrocytes.
Xie L; Zhang N; Zhang Q; Li C; Sandhu AF; Iii GW; Lin S; Lv P; Liu Y; Wu Q; Yu S
Aging (Albany NY); 2020 Nov; 12(22):22538-22549. PubMed ID: 33196457
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-β-Induced Inflammatory Response in vivo and in vitro.
Dorey E; Bamji-Mirza M; Najem D; Li Y; Liu H; Callaghan D; Walker D; Lue LF; Stanimirovic D; Zhang W
J Alzheimers Dis; 2017; 57(4):1265-1279. PubMed ID: 28372324
[TBL] [Abstract][Full Text] [Related]
9. Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease.
Beggiato S; Cassano T; Ferraro L; Tomasini MC
Life Sci; 2020 Sep; 257():118037. PubMed ID: 32622942
[TBL] [Abstract][Full Text] [Related]
10. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
[TBL] [Abstract][Full Text] [Related]
11. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of Chunghyuldan from amyloid beta oligomer induced neuroinflammation in vitro and in vivo.
Kim HG; Kim JY; Whang WW; Oh MS
Can J Physiol Pharmacol; 2014 Jun; 92(6):429-37. PubMed ID: 24820962
[TBL] [Abstract][Full Text] [Related]
13. The combination of acyclovir and dexamethasone protects against Alzheimer's disease-related cognitive impairments in mice.
Hui Z; Zhijun Y; Yushan Y; Liping C; Yiying Z; Difan Z; Chunglit CT; Wei C
Psychopharmacology (Berl); 2020 Jun; 237(6):1851-1860. PubMed ID: 32221697
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease.
Salles GN; Calió ML; Hölscher C; Pacheco-Soares C; Porcionatto M; Lobo AO
Neuropharmacology; 2020 Jan; 162():107813. PubMed ID: 31628935
[TBL] [Abstract][Full Text] [Related]
15. Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation.
Fu W; Vukojevic V; Patel A; Soudy R; MacTavish D; Westaway D; Kaur K; Goncharuk V; Jhamandas J
J Neuroinflammation; 2017 Oct; 14(1):199. PubMed ID: 28985759
[TBL] [Abstract][Full Text] [Related]
16. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease.
Fang F; Lue LF; Yan S; Xu H; Luddy JS; Chen D; Walker DG; Stern DM; Yan S; Schmidt AM; Chen JX; Yan SS
FASEB J; 2010 Apr; 24(4):1043-55. PubMed ID: 19906677
[TBL] [Abstract][Full Text] [Related]
17. Glia as a therapeutic target: selective suppression of human amyloid-beta-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration.
Ralay Ranaivo H; Craft JM; Hu W; Guo L; Wing LK; Van Eldik LJ; Watterson DM
J Neurosci; 2006 Jan; 26(2):662-70. PubMed ID: 16407564
[TBL] [Abstract][Full Text] [Related]
18. KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease.
Yi M; Yu P; Lu Q; Geller HM; Yu Z; Chen H
Mol Cell Neurosci; 2016 Oct; 76():21-32. PubMed ID: 27567685
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells decrease C3-positive reactive astrocytes in Alzheimer-like pathology.
Stym-Popper G; Matta K; Chaigneau T; Rupra R; Demetriou A; Fouquet S; Dansokho C; Toly-Ndour C; Dorothée G
J Neuroinflammation; 2023 Mar; 20(1):64. PubMed ID: 36890536
[TBL] [Abstract][Full Text] [Related]
20. GLP-1 improves the neuronal supportive ability of astrocytes in Alzheimer's disease by regulating mitochondrial dysfunction via the cAMP/PKA pathway.
Xie Y; Zheng J; Li S; Li H; Zhou Y; Zheng W; Zhang M; Liu L; Chen Z
Biochem Pharmacol; 2021 Jun; 188():114578. PubMed ID: 33895160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
